January 19, 2018
Posted by wordae on Friday, January 19, 2018 in Uncategorized.
This week our team has created a quality function deployment (QFD) for our device based on the comments we obtained from physicians and technicians t the Vanderbilt Eye Institute in December (below). The design factors that we identified as most important to our designs are the headrest, eyepiece, and device enclosure.
The QFD helped inform the four designs that we each separately formulated this week. Khairah and Anna each created one design, and Sophie created two. All are designed for more portability and adjustability than Halma’s current device. Judy also translated one of Sophie’s designs into a rough CAD model.
This week Judy has also been working on identifying contraindications that would interfere with our test. She identified several SSRI, SNRI, and acetylcholinergic medications that have vision-related side effects such as blurry vision that could alter the accuracy of the test. This important because we want to ensure that no population is barred from using this device because of their medications.
In the future, we will be creating more detailed CAD models based on feedback that we plan to obtain from the Vanderbilt Eye Institute. Additionally, Judy will do research to expand our current list of contraindications.